Cargando…
Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
BACKGROUND: The aim of the study was to assess the impact of CD133-positive (CD133+) cancer stem cell proportions on treatment results of glioblastoma multiforme (GBM) patients. PATIENTS AND METHODS: Patients with GBM (n = 42) received postoperative radiotherapy (± chemotherapy). Surgically excised...
Autores principales: | Kase, Marju, Minajeva, Ave, Niinepuu, Kristi, Kase, Sandra, Vardja, Markus, Asser, Toomas, Jaal, Jana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814287/ https://www.ncbi.nlm.nih.gov/pubmed/24294187 http://dx.doi.org/10.2478/raon-2013-0055 |
Ejemplares similares
-
Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients
por: Minajeva, Ave, et al.
Publicado: (2017) -
VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment
por: Jaal, Jana, et al.
Publicado: (2015) -
Expression of immune checkpoint PD-1 in non-small cell lung cancer is associated with tumor cell DNA-dependent protein kinase
por: Saar, Marika, et al.
Publicado: (2021) -
Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets
por: Lavogina, Darja, et al.
Publicado: (2021) -
CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018)